12 completed, 7 unknown, 5 recruiting, 5 terminated. 9 Not applicable, 7 Phase 2, 5 Phase 3, 3 Phase 1, 1 Early Phase 1.
Follow Lung Infection: new trials by email Literature Review of Lung Infection trials Research Report on Lung Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FMT for Lung and Associated-organ Rescue Efficacy in MDRO-infected Ventilated Patients Fecal suspension - Lung Infection, Microbial Colonization | Not applicable | Withdrawn | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2026-09-20 | 2026-09-02 | |
| Radiolabelled Nectin-4 Targeted LMW Probe PET/CT in Patients With Lung Lesions FDG-PET - Lung Cancer, Non-Small Cell, Lung Infection | Recruiting | Peking University Cancer Hospital & Institute | 20 | 2024-11-21 | 2024-11-25 | |
| Next-generation Sequencing Technology in the Clinical Application of Respiratory Specimens Lung Infection | Enrolling by invitation | Bin Zhang | 80 | 2024-10-01 | 2025-09-24 | |
| Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath Gas chromatography-mass spectrometry(GC-MS) and micro Gas Chromatography-photoionisation detector (μGC-PID) system - Lung Cancer, Lung Infection | Recruiting | ChromX Health | 10000 | 2024-06-30 | 2025-03-26 | |
| Evaluation of Virtual Reality to Reduce Anxiety, Pain and Duration of Non-emergency Vigile Bronchial Fibroscopy (AVATAR) Virtual reality headset - Respiratory Disorder, Lung Infection | Not applicable | Unknown | Assistance Publique - Hôpitaux de Paris | 120 | 2023-10-19 | 2024-12-04 |
| A Study of the Clinical Benefit of Tobramycin Inhalation Solution Tobramycin inhalation solution - Bronchiectasis, Cystic Fibrosis | Active not recruiting | Qianfoshan Hospital | 1600 | 2023-04-01 | 2024-10-17 | |
| Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection AP-PA02, Placebo - Non-cystic Fibrosis Bronchiectasis, Pseudomonas Aeruginosa | Phase 2 | Completed | Armata Pharmaceuticals, Inc. | 48 | 2023-01-10 | 2026-01-05 |
| Effects of Prone Position After Major Abdominal Surgery prone position - Surgery, Complications, Postoperative | Not applicable | Recruiting | Vastra Gotaland Region | 200 | 2022-10-01 | 2024-05-30 |
| Population Pharmacokinetics of Lassila Tazobactam in Patients After Aortic Dissection continuous renal replacement therapy - Aortic Dissection, Lung Infection | Unknown | The Second Hospital of Shandong University | 50 | 2022-04-30 | 2022-04-27 | |
| TAAI Erasmus Research Initiative to Fight CF: Monitoring Inflammation in CF Lung Disease Into a New Era Cystic Fibrosis, Lung Inflammation | Completed | Erasmus Medical Center | 103 | 2022-03-21 | 2025-07-18 | |
| Aerosolisation During Respiratory Procedures Not an interventional study - Healthy, Respiratory Tract Infections | Unknown | Guy's and St Thomas' NHS Foundation Trust | 10 | 2021-03-01 | 2021-02-15 | |
| Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis AP-PA02, Placebo - Cystic Fibrosis, Pseudomonas Aeruginosa | Phase 1 / Phase 2 | Completed | Armata Pharmaceuticals, Inc. | 29 | 2020-12-22 | 2024-01-31 |
| Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders HP 3He, HP 129Xe, PFP - Lung Transplant, Lung Resection | Early Phase 1 | Terminated | Thunder Bay Regional Health Research Institute | 10 | 2020-11-10 | 2024-10-15 |
| COVID-19 and Lung Ultrasound Utility Butterfly iQ - Covid19, Lung Infection | Not applicable | Completed | Bridge to Health Medical and Dental USA | 6 | 2020-09-15 | 2021-07-14 |
| Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia Opaganib, Placebo - COVID-19, Lung Infection | Phase 2 / Phase 3 | Completed | RedHill Biopharma Limited | 475 | 2020-08-21 | 2025-07-31 |
| Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen Opaganib - COVID-19, Lung Infection | Phase 1 / Phase 2 | Withdrawn | RedHill Biopharma Limited | 2020-08-01 | 2020-08-11 | |
| Effects of Immunonutrition in Patients With Pneumonia Oral Impact powder - Pneumonia, Lung Infection | Not applicable | Unknown | University of Copenhagen | 40 | 2020-03-30 | 2020-04-28 |
| The Effect of Long Term Therapy With High Flow Humidification Compared to Usual Care in Patients With Bronchiectasis (BX) High Flow Humidification - Bronchiectasis Adult, Lung Infection | Not applicable | Unknown | Dr. Giuseppe Fiorentino | 160 | 2019-09-04 | 2019-10-29 |
| Diagnosis of Lung Complication After Allo-HSCT by Multiple Parameter System Through BAL Bronchoscopic Alveolar Lavage - Bronchoalveolar Lavage Fluid, Lung Infection | Unknown | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 250 | 2019-08-30 | 2019-08-09 | |
| Adjunctive Therapy to Antibiotics in the Treatment of S. Aureus Ventilator-Associated Pneumonia With AR-301 AR-301, Placebo - Lung Infection, Pneumonia, Ventilator-Associated | Phase 3 | Completed | Aridis Pharmaceuticals, Inc. | 174 | 2019-05-03 | 2023-07-06 |
Showing 20 of 33. Sign in to see all of them.
Cystic Fibrosis (11) · Pneumonia (5) · Bronchiectasis (4) · Lung Diseases (4) · Pseudomonas Infections (4) · COVID-19 (3) · Infections (3) · Lung Neoplasms (3) · Asthma (2) · Bacterial Infections (2) · Emphysema (2) · Lung Diseases, Interstitial (2) · Pulmonary Disease, Chronic Obstructive (2) · Pulmonary Embolism (2) · Pulmonary Fibrosis (2)
Respiratory Tract Diseases (22) · Lung Diseases (16) · Infections (15) · Digestive System Diseases (11) · Genetic Diseases, Inborn (11) · Infant, Newborn, Diseases (11) · Pancreatic Diseases (11) · Pathological Conditions, Signs and Symptoms (11) · Bacterial Infections and Mycoses (10) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (10) · Respiratory Tract Infections (10) · Pathologic Processes (8) · Bacterial Infections (7) · Disease Attributes (5) · Gram-Negative Bacterial Infections (5)
3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide (2) · Azithromycin (1) · Aztreonam (1) · Clarithromycin (1) · Continuous Renal Replacement Therapy (1) · Drug Delivery Systems (1) · Ethambutol (1) · Inhalation (1) · Prone Position (1) · Rifampin (1) · Sulfur Hexafluoride (1) · interferon gamma-1b (1) · perflutren (1) · rhubarb peony decoction (1)
Armata Pharmaceuticals, Inc. (2) · Brazilian Institute of Higher Education of Censa (2) · Gilead Sciences (2) · RedHill Biopharma Limited (2) · Aridis Pharmaceuticals, Inc. (1) · Assistance Publique - Hôpitaux de Paris (1) · Bin Zhang (1) · Bridge to Health Medical and Dental USA (1) · CENTOGENE GmbH Rostock (1) · Centre Hospitalier Universitaire, Amiens (1) · ChromX Health (1) · Dr. Giuseppe Fiorentino (1) · Erasmus Medical Center (1) · Fudan University (1) · Guy's and St Thomas' NHS Foundation Trust (1)
United States (8) · China (7) · Brazil (4) · France (4) · Canada (3) · Israel (3) · Georgia (2) · Italy (2) · Mexico (2) · Russia (2) · United Kingdom (2) · Albania (1) · Australia (1) · Belarus (1) · Belgium (1)
Mark L Levitt, MD (2) · Birgitte L Madsen, M.D., Ph.D. (1) · Cecilia Engstrom Mattisson, MD PhD (1) · Christopher H. Goss, MD MSc (1) · Claire Wainwright, MD (1) · Erin P Silverman, PhD (1) · Gaetan Gavazzi (1) · George Retsch-Bogart, MD (1) · Hasan S Jafri, MD, FAAP (1) · Jason Akulian (1) · Jianxing He, MD (1) · Maria Theresa Basco, MD, MPH (1)
PMID 12464864, PMID 21441078, PMID 22549749, PMID 25592656, PMID 31618346, PMID 32800708, PMID 35584850, PMID 35762891, PMID 36517740, PMID 37541984